Leading European growth buyout investor with 25+ years specialising in profitable Technology and Healthcare companies generating €10-400M revenue. €5.5B AUM with 39% gross IRR across 69 companies.
Focus and check size from the firm's website. Website reachable as of Oct 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.